The infant formula ingredients market demonstrates reasonable expansion predictions from 2025 through 2035 because of rising worldwide birth numbers as well as increasing parental understanding about infant nutrition and escalating preferences for premium, nutritionally balanced baby formula products.
The ingredients used in these formulas carry out a vital function to duplicate breast milk nutrition thus enabling proper infant growth. The Infant Formula Ingredients industry will grow at a compound annual rate of 6% from 2025 to 2035 resulting in a market value increase from USD 48,187.5 million to USD 86,296.5 million.
The market grows because mother's employment rates increase while formula composition advances and emerging economies embrace infant formula. The application of human milk oligosaccharides (HMOs) together with omega-3 fatty acids and plant-based proteins develops better nutrition throughout different product lines in formula development.
The market faces obstacles from complex regulations as well as the sensitive nature of product prices and increasing support for breastfeeding among various groups. Factories employ visible packaging and advanced nutritional research alongside beneficial microbe ingredients as a means to help digestive health while supporting overall immunity.
Key Market Metrics
| Metric | Value |
|---|---|
| Industry Size (2025E) | USD 48,187.5 Million |
| Industry Value (2035F) | USD 86,296.5 Million |
| CAGR (2025 to 2035) | 6% |
The infant formula ingredients market functions through ingredient type divisions and formula stage segments while primarily serving infant food producers together with paediatric nutrition supply providers. The market contains key ingredients which include proteins and carbohydrates together with fats and oils along with vitamins and minerals while specialty components contain probiotics and human milk oligosaccharides.
Whey protein and casein proteins lead the nutritional content as essential amino acids necessary for infant growth. Fats & oils together with specialty ingredients serve to support developmental growth of the brain and provide energy source while improving digestive health and immune response.
Stage 1 formula for babies under six months old controls the maximum market share because new-borns need complete nutritional content. Asia-Pacific leads the market growth in Stage 2 and 3 infant formula sales at ages six to twelve months and above twelve months. The manufacturing industry focuses on producing products with clean labels that contain no allergies and organic contents to address shifting parent requirements.
Explore FMI!
Book a free demo
The North America infant formula ingredients market maintains strong performance because customers understand infant nutrition needs well thus driving organic formula and premium ingredients adoption. The United States along with Canada engage in substantial research and development activities which result in market expansion dedicated to immune-boosting components and plant-based formula ingredients.
This market thrives because the region has vigorous oversight from regulators as well as strong health-focused attitudes among consumers who increasingly look for formula with clean labels and without allergens. European manufacturers emphasize the development of formula products containing probiotics and omega-3s and HMOs to maintain product safety and nutritional value in Germany France and the United Kingdom.
The infant formula ingredients market grows at its fastest rate within the Asia-Pacific region due to quick urban development together with rising family wealth and massive total number of infants. China, India, Japan, and Australia witness high demand for stage-wise formulas with premium ingredients.
Market expansion receives motivation from multiple government programs that advocate child nutrition and from domestic manufacturing initiatives in the region. The infant formula ingredients market in the Asia-Pacific region expands due to changing consumer tastes that favour premium science-based nutritional choices but cost factors still play a significant role.
Challenge: Regulatory Scrutiny and Product Safety Standards
The infant formula ingredients market is witnessing stringent and regulatory scrutiny affecting the quality and safety standards and hence this acts as a deterrent for the market. A key requirement is that the ingredients used in the infant formulas, such as proteins, fats, carbohydrates, vitamins, and minerals, are similar in composition to that of the human breast milk, while also adhering to strict global food safety regulations.
Agencies including FDA, EFSA, and Codex Alimentary require detailed approval paths, quality certifications, and compliance assessments that ultimately lengthen development paths and raise the cost for manufacturers. Allergen risks, ingredient authenticity and product contamination are also forces for producers to maintain strong traceability and quality assurance systems through their supply chains.
Opportunity: Innovation in Human Milk Mimicry and Organic Formulations
The increasing need for science-backed, premium products addressing infant nutrition opens a highly attractive opportunity for ingredient innovation. Manufacturers are designing bioactive ingredients including human milk oligosaccharides (HMOs), lactoferrin, nucleotides and prebiotics aiming to closely replicate all of the immune and digestive benefits of breast milk. At the same time, growing consumer preferences for clean-label, organic, non-GMO, and plant-based infant formulas drive adoption of vegetarian forms of DHA, organic lactose, and hydrolysed plant proteins.
Protein properties can be modified for enhanced digestibility and bioavailability with new technological advances such as enzymatic processing, fermentation, and lipid structuring, paving the way for next-generation infant formulas to target specific nutrition needs for children requiring hypoallergenic and lactose-free formulas.
In 2020 and 2024, steady growth in the infant formula market helped to accommodate increasing demand for premium and specialty formulas, such as products designed for the specialized medic- al needs of a cow milk allergy, pre-term infant, and digestive comfort.
Manufacturers began to concentrate on improving the nutritional constituents and digestibility of densified products whereby the incorporation of probiotics, omega-3 fatty acids and antibiotic-free organic lactose became prevalent. But product development and availability in some markets were hindered by supply chain disruptions, regulatory delays and global ingredient shortages.
While the market will shift toward personalized and functional infant nutrition between 2025 and 2035, it will be firmly anchored by advances in biotechnology, microbiome science, and AI exposure-based formulation platforms. Ingredient innovation will include customizing formulas for individual health profiles, while sustainable sourcing of dairy and vegetable inputs will be increasingly pursued.
Alternatives emerging from precision fermentation, lab-grown proteins and human milk cell cultivation will usher in the next generation of ingredient solutions, improving how closely formula can mimic breast milk and minimizing the industry's dependence on traditional animal-based sources.
Market Shifts: A Comparative Analysis (2020 to 2024 vs. 2025 to 2035)
| Market Shift | 2020 to 2024 |
|---|---|
| Regulatory Landscape | Tight global regulation on ingredient safety and nutritional compliance. |
| Technological Advancements | Use of probiotics, DHA, and lactose derivatives in standard formulas. |
| Sustainability Trends | Evolving toward organic ingredients and transparent supply chains |
| Market Competition | Dominated by established dairy-based formula providers. |
| Industry Adoption | Common in standard formulas and allergen-reduced variants. |
| Consumer Preferences | Demand for clean-label and organic-certified infant nutrition. |
| Market Growth Drivers | Growth fuelled by urbanization, rising birth rates in emerging economies, and premium trends. |
| Market Shift | 2025 to 2035 |
|---|---|
| Regulatory Landscape | Standardization of human milk-based bioactive and AI-aided formulation approvals. |
| Technological Advancements | Introduction of precision-fermented HMOs, lab-cultured lactoferrin, and AI-optimized blends. |
| Sustainability Trends | Plant-based, carbon-neutral, and humane ingredient sourcing goes mainstream |
| Market Competition | Entry of biotech firms and plant-based innovators targeting functional infant nutrition. |
| Industry Adoption | Expanded use in microbiome-specific, immune-boosting, and growth-optimized formulations. |
| Consumer Preferences | Preference for customized, bioactive-rich, and breast milk-equivalent formulations. |
| Market Growth Drivers | Expansion driven by biotech breakthroughs, sustainability demands, and personalized infant health solutions. |
The USA infant formula ingredients market is flourishing, owing to rising demand for premium-quality nutritionally balanced baby food and increasing number of working mothers choosing formula-based feeding. Interest in organic, non-GMO, and DHA-rich formulations that replicate the nutritional profile of breast milk is driving the market.
Consumer awareness is higher than ever about functional ingredients, such as probiotics, nucleotides and milk fat globule membrane (MFGM), and regulatory support from the FDA, along with the involvement of key industry players, has accelerated the development of customized blends. The expansion of e-commerce, along with consumer education, has improved access to specialty formulas for infants with dietary sensitivities or allergies.
| Country | CAGR (2025 to 2035) |
|---|---|
| USA | 6.2% |
Increased global focus on early childhood nutrition alongside the demand for clean-label products are some of the factors positively impacting the UK infant formula ingredients market. As infant gut health and inherently associated immunity gain awareness; infant formula manufacturing companies are focusing on formulations that include prebiotic & probiotic enrichment as well as vitamins & minerals fortification.
The post-pandemic consumer focus on health-conscious parenting becomes even more combined with stronger regulatory scrutiny through the eyes of the Food Standards Agency (FSA) enables innovation in all aspects of plant proteins and organic carbohydrate blends. The UK also makes a positive contribution to the European supply chain through imports and exports of high-grade infant nutrition ingredients.
| Country | CAGR (2025 to 2035) |
|---|---|
| UK | 5.9% |
The market for infant formula ingredients in the European Union is growing strongly, supported by strict EU regulations related to product safety and nutritional quality as well as increasing consumer preference for clean, organic, and sustainable sources of ingredients. Germany, France and the Netherlands are large producers and exporters of ingredients for dairy-based and specialty formula.
There's a growing need for advanced protein sources, oligosaccharides, and lactose derivatives throughout the region. And innovation in bioactive compounds and allergen-friendly formulations is generating opportunities for ingredient manufacturers. The infant health research being supported by the EU is also providing value to R&D to fortify next-gen infant formula.
| Region | CAGR (2025 to 2035) |
|---|---|
| European Union | 6.1% |
Japan already has an infant formula ingredients market fuelled by an ageing population accompanied by falling birth rates and by premium and highly specialized infant nutrition. Japanese consumers are focused on quality, traceability, and functional health benefits and manufacturers are responding with advanced bioactive compounds, lactoferrin-enriched formulas, and immune-boosting additives.
Additionally, the nation’s tech skills in dairy processing and infant health science is elevating the development of fermented formula ingredients as well as plant-based alternatives. Japan's regulatory landscape, governed by the Ministry of Health, Labour and Welfare, mandates stringent adherence and quality assurance, bolstering confidence among consumers.
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 6.0% |
The South Korea baby formula ingredients market is booming due to increasing parent accessibility to higher-value convenience and raising disposable income, which is boosting higher-value consumer spending on customized infant nutrition segments. Parents are increasingly opting for premium formulations fortified with omega-3s, human milk oligosaccharides (HMOs), and digestive enzymes to meet diverse infant health needs.
Moreover, stringent governance and a focus on food safety are driving ingredient suppliers to be adaptable to more transparent, traceable, and allergen-free ingredients. The demand for next-generation formula ingredients in immunity and cognitive development is now being supported by South Korea's innovation in functional food ingredient and biotechnology-derived nutrients.
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 6.0% |
As priorities in global infant nutrition evolve away from breastmilk and towards digestive health, immune support and nutrient-rich alternatives, the infant formula ingredients market is growing at an accelerated pace. Among all ingredient types used in formula production, fats & oils and prebiotics are leading the segments, accounting for the largest share of value attributed due to their indispensable role in infant growth, cognitive development, and gastrointestinal function.
As infant formula manufacturers move towards increasingly complex products, one solution is for manufacturers to increasingly create blends of ingredients that are bioavailable, clinically tested, and functional, to try to replicate the components of human milk.
The increasing popularity of advanced ingredients in nutrition products such as structured lipids, DHA-enriched oils, and oligosaccharide-based prebiotics that ensure gut microbiota balance, immune system support and brain development of the child has led to preference for advanced nutrition in early stages of the growing problem.
As demand for premium infant nutrition continues to grow in emerging markets, companies are investing in sustainable sourcing, traceability technologies, and hypoallergenic ingredient formulations that can match a range of infant needs and parental expectations.
As a result of the social health needs associated with feeding and how to make it available through food related small and medium enterprises. Fats & oils leading the market demand in between macronutrients required for brain development and providing the required energy.
Fats & oils are a crucial element of infant formula providing as much as 50% of caloric value. These macros are also the major source of fuel, but they’re also important for proper brain development, nervous system maturation and absorption of fat-soluble vitamins. Manufacturers of infant formula utilize vegetable oils, structured triglycerides, and long-chain polyunsaturated fatty acids (LCPUFAs) DHA (docosahexaenoic acid) and ARA (arachidonic acid) to aim for a similar lipid profile to that found in breast milk.
Blends typically include oils, from palm, coconut, soy, sunflower and canola that are adjusted for digestibility, fatty acid profiles and oxidative stabilization. The recent innovation has particularly concentrated on custom triglyceride constructs that, in some cases, can facilitate fat absorption while reducing intestinal anxiety, including that experienced by preterm or low-birth-weight neonates.
Fats & oils will always be one of the key ingredient categories included in any formula composition, and with the evolution of our science around early nutrition and its impact on later life cognitive outcomes, it can only become an even more critical choice in formula.
While certain oils especially palm oil are facing regulatory scrutiny, manufacturers are getting creative with sustainable alternatives, like algal oil for DHA and high-oleic sunflower oil, both of which provide clean-label, plant-based and non-GMO options. Continued demand for tailored fat compositions for the processing of infant formula has been extending with the inclusion of structured lipid blends that are age-group specific and growth stage specific.
With increasing numbers of parents looking for high-performance infant formula that supports brain health, vision health and fat metabolism, the demand for DHA-rich, sustainably sourced and easily digested fats and oils continues to grow.
Most Premium and Specialty formulas include these ingredients to improve nutrient bioavailability, especially in infants with digestive sensitivities or rapid developmental requirements. Plant-based interests are on the rise, but oil innovation is key in formulations aimed at vegan parents, lactose-free diets and environmentally conscious consumers.
They serve as one of the beneficial prebiotic functional ingredients in infant formula that support gut microbiome development, mineral and iron absorption, and immune modulation. These non-digestible carbohydrates fructooligosaccharides (FOS) and galactooligosaccharides (GOS) serve as prebiotics, nourishing beneficial gut probiotics and replicating the microbiota benefits of breastmilk.
The additions of prebiotics to infant formulas also improve stool consistency, colic, and promote bifid bacteria and lactobacilli growth to aid in early life immune maturation. Supported by increasing scientific evidence relating gut health with immunity, cognitive development and allergy prevention, prebiotics have emerged as an important functional ingredient in both our traditional and specialty infant formula products.
Top manufacturers are also working on prebiotic mixes containing a number of oligosaccharides to improve diversity in the gut microbiome. Some formulations are symbiotic blends that combine prebiotics with probiotics or postbiotics, synergistically improving overall gut flora stability and digestive efficiency. Also, the cost-effective manufacturing of prebiotics small molecule products for large scales of production in infant formula applications is being propelled by state-of-the-art advancements in plant-based extraction, fermentation technologies, and molecular stability.
With growing emphasis on early gut microbiome development and targeted gut microbiome modulation of infant gut microbiota, particularly in formula-fed infant’s prebiotics have become a first-class ticket available in many premium and functional infant nutrition products.
Its role in supporting natural defences, reducing the risk of infection, and improving the use of nutrients makes them well suited to infants with impaired immunity or digestive problems. With clean-label preferences taking centre stage alongside clinical validation in the consumer journey, prebiotics are projected to unlock sustained growth in all age-based formula applications.
The largest application segment of the market is infant formula developed for the 0>6 months age group. The early stage is characterized by the most intense growth in physical and neurological aspects, therefore issues with the nutritional composition that play a healthy role in breast milk need to be replicated in the closest possible way.
In such a competitive segment, ingredient selection is particularly important, as these products must replicate the formula more closely than ever, including protein composition, fatty acid profile, and micronutrient density.
Infant formulas designed for this group focus on the balance between whey and casein proteins, inclusion of DHA and ARA fatty acids, lactose as the predominant carbohydrate source, and bioavailable mineral formulations. Furthermore, goods in this group combine prebiotics and nucleotides to assist the growth of the immune system and gastrointestinal system.
For some in this category, such as non-lactating mothers, mothers who had adopted babies, or medical conditions that prevent nursing, formula may be the only form of nutrition available to newborns.
As such, all components added to 0-6-month formulas must adhere to stringent regulatory standards for food safety, sterility, and digestibility in the sensitive segment. OEMs are investing in clinical trials, nutrition modelling and biochemical resource development initiatives to assure product safety and efficacy for newborns.
The infant formula ingredients industry is evolving rapidly, with such essential components as fats & oils and prebiotics playing key roles in the pursuit of safe, digestible, and nutritionally complete substitutes for breast milk. Particularly for formula products aimed at the 0 to 6-month demographic, these ingredients are essential to establishing gut health, brain development, and immunity.
Given evolving regulatory standards, rising consumer demands for functional nutrition, sustainability, and ingredient transparency, manufacturers are all set for innovation with clean-label, scientifically credentialed, and globally compliant infant nutrition solutions.
The infant formula ingredients represents an extensive landscape, with a myriad of players thriving in the space owing to the growing global demand for safe, nutritionally complete and easy-to-digest formula products for infants. That's because these ingredients are key to mirroring the composition of breast milk, particularly with regard to its proteins, fats, carbohydrates, vitamins, minerals and functional additives.
Leading players have focused on clinical validation, clean-label formulations, and advanced processing technologies to enhance digestibility, immune support and cognitive development. It services millennial consumers, offering formula manufacturers the premium and mass-market solutions as global dairy ingredient suppliers, specialty nutrition related companies and food science innovators.
Market Share Analysis by Company
| Company Name | Estimated Market Share (%) |
|---|---|
| Friesland Campina Ingredients | 18-22% |
| Fonterra Co-operative Group | 15-19% |
| Arla Foods Ingredients Group P/S | 12-16% |
| BASF SE | 8-12% |
| Kerry Group plc | 5-9% |
| Other Companies (combined) | 30-40% |
| Company Name | Key Offerings/Activities |
|---|---|
| Friesland Campina Ingredients | Produces human milk oligosaccharides (HMOs), whey proteins, and lipid blends, optimized for digestibility and cognitive development. |
| Fonterra Co-operative Group | Offers whey protein isolates, lactose, and milk fat globule membrane (MFGM), catering to premium infant formula manufacturers. |
| Arla Foods Ingredients Group P/S | Specializes in lactose, alpha-lactalbumin, and mineral blends, focusing on gut health and immune system development. |
| BASF SE | Develops functional lipids such as DHA and ARA, along with vitamins and micronutrients essential for early-stage infant nutrition. |
| Kerry Group plc | Provides probiotic cultures, plant-based proteins, and flavour-masking technologies, enhancing digestive support and palatability. |
Key Company Insights
Friesland Campina Ingredients
Friesland Campina leads in functional infant formula ingredients, producing HMOs, prebiotics, and protein blends that closely mimic the benefits of breast milk.
Fonterra Co-operative Group
Fonterra supplies premium dairy-derived ingredients, including bioactive proteins and MFGM, tailored for immune health and neurodevelopment in infants.
Arla Foods Ingredients Group P/S
Arla Foods Ingredients focuses on high-purity alpha-lactalbumin and mineral systems, designed to improve digestion and support infant gut microbiota.
BASF SE
BASF delivers high-quality functional lipids (DHA/ARA) and vitamin complexes, ensuring balanced growth and immune system fortification in infant formula products.
Kerry Group plc
Kerry Group specializes in probiotic and enzymatic solutions, supporting digestive comfort, nutrient absorption, and enhanced flavour profiles in infant formulas.
Other Key Players (30-40% Combined)
Several other companies contribute to the infant formula ingredients market, focusing on clinical-grade formulations, sustainable sourcing, and nutritional innovations:
The overall market size for the infant formula ingredients market was USD 48,187.5 million in 2025.
The infant formula ingredients market is expected to reach USD 86,296.5 million in 2035.
The increasing demand for high-nutrition alternatives to breast milk, rising awareness of infant health, and growing inclusion of functional ingredients in infant formulas fuel the infant formula ingredients market during the forecast period.
The top 5 countries driving the development of the infant formula ingredients market are the USA, UK, European Union, Japan, and South Korea.
Fats & oils and prebiotics lead market growth to command a significant share over the assessment period.
USA Bubble Tea Market Analysis from 2025 to 2035
Food Testing Services Market Trends - Growth & Industry Forecast 2025 to 2035
USA Dehydrated Onions Market Insights – Size, Trends & Forecast 2025-2035
Latin America Dehydrated Onions Market Outlook – Demand, Share & Forecast 2025-2035
Europe Dehydrated Onions Market Analysis – Growth, Trends & Forecast 2025-2035
ASEAN Dehydrated Onions Market Trends – Size, Demand & Forecast 2025-2035
Infant Formula Ingredients Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
